The Harvard Hedge Fund?

A blog post by Matthew Yglesias ’03 has sparked quite a lively debate about whether Harvard deserves its tax-exempt status...

A blog post by Matthew Yglesias ’03 has sparked quite a lively debate about whether Harvard deserves its tax-exempt status. This is all a response to a bill being debated in the Massachusetts legislature to tax college endowments exceeding $1 billion.

Yglesias, a blogger for TheAtlantic.com, starts by quoting another blogger's comparison of Harvard's endowment to "a $40 billion tax-free hedge fund with a very large marketing and PR arm called Harvard University." Comments from site visitors draw in a cornucopia of related issues: tuition, financial aid, admissions policies, the general role of elite universities in society.

You can even add your two cents if you scroll down to the bottom of the page.

Related topics

You might also like

A History of Harvard Magazine

Harvard’s independent alumni magazine—at 127 years old 

A (Truly) Naked Take on Second-Wave Feminism

Playwright Bess Wohl’s Liberation opens on Broadway.

Most popular

What Trump Means for John Roberts’s Legacy

Executive power is on the docket at the Supreme Court.

The Life of a Harvard Spy

Richard Skeffington Welch’s illustrious—and clandestine—career in the CIA

Harvard’s Class of 2029 Reflects Shifts in Racial Makeup After Affirmative Action Ends

International students continue to enroll amid political uncertainty; mandatory SATs lead to a drop in applications.

Explore More From Current Issue

Six women interact in a theatrical setting, one seated and being comforted by others.

A (Truly) Naked Take on Second-Wave Feminism

Playwright Bess Wohl’s Liberation opens on Broadway.

Illustration of tiny doctors working inside a large nose against a turquoise background.

A Flu Vaccine That Actually Works

Next-gen vaccines delivered directly to the site of infection are far more effective than existing shots.

Professor David Liu smiles while sitting at a desk with colorful lanterns and a figurine in the background.

This Harvard Scientist Is Changing the Future of Genetic Diseases

David Liu has pioneered breakthroughs in gene editing, creating new therapies that may lead to cures.